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Abstract
Background: Inflammation acting in synergy with brain ischemia aggravates perinatal ischemic brain damage. The
sensitizing effect of pro-inflammatory exposure prior to hypoxia is dependent on signaling by TNF-a through TNF
receptor (TNFR) 1. Adrenoceptor (AR) activation is known to modulate the immune response and synaptic
transmission. The possible protective effect of   and   AR activation against neuronal damage caused by tissue
ischemia and inflammation, acting in concert, was evaluated in murine hippocampal organotypic slices treated
with lipopolysaccharide (LPS) and subsequently subjected to oxygen-glucose deprivation (OGD).
Method: Hippocampal slices from mice were obtained at P6, and were grown in vitro for 9 days on nitrocellulose
membranes. Slices were treated with b1(dobutamine)-, b2(terbutaline)-, a1(phenylephrine)- and a2(clonidine)-AR
agonists (5 and 50 μM, respectively) during LPS (1 μg/mL, 24 h) -exposure followed by exposure to OGD (15 min)
in a hypoxic chamber. Cell death in the slice CA1 region was assessed by propidium iodide staining of dead cells.
Results: Exposure to LPS + OGD caused extensive cell death from 4 up to 48 h after reoxygenation. Co-incubation
with b1-agonist (50 μM) during LPS exposure before OGD conferred complete protection from cell death (P <
0.001) whereas the b2-agonist (50 μM) was partially protective (p < 0.01). Phenylephrine was weakly protective
while no protection was attained by clonidine. Exposure to both b1- and b2-agonist during LPS exposure
decreased the levels of secreted TNF-a, IL-6 and monocyte chemoattractant protein-1 and prevented microglia
activation in the slices. Dobutamine remained neuroprotective in slices exposed to pure OGD as well as in TNFR1
-/-
and TNFR2
-/- slices exposed to LPS followed by OGD.
Conclusions: Our data demonstrate that activation of both b1- and b2-receptors is neuroprotective and may offer
mechanistic insights valuable for development of neuro-protective strategies in neonates.
Background
Perinatal hypoxia-ischemia remains an important cause
of brain damage which may result in long-term impair-
ment including cerebral palsy and mental retardation.
Hypoxia-ischemia occurs as result of disturbed gaseous
exchange between mother and fetus, most commonly
occurring during labor at birth.
The normal transition from fetal to neonatal life, ie
birth, is associated with a surge of circulating catechola-
mines (CA) which is several-fold higher than during
normal conditions [1]. We have shown that preterm
infants exhibit a circulating anti-inflammatory response
with a homogenous increase in IL-10 during the first
postnatal hours [2]. We speculated that CA release at
very preterm birth may be causal in generating a circu-
lating anti-inflammatory response. This is supported by
in vitro studies showing that exposure of both peripheral
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causes a suppression of stimulated release of the pro-
inflammatory cytokine TNF-a with an increase in IL-10
[3,4].
Fetal hypoxia per se is associated with an increase in
circulating CA. The main source of circulating CA is
the fetal adrenomedullary system [5]. The chromaffine
cells of the adrenal medulla are directly sensitive to low
pO2,e l e v a t e dp C O 2 and decreased pH resulting in
release of norepinephrine (NE) and epinephrine. Of
note, the adrenomedullary response to these stressors,
which accompany fetal asphyxia, is functional during the
perinatal period and is decreased in later development
following splanchnic innervation of the adrenal medulla.
The surge of NE and E has been shown to be essential
for cardiovascular compensation to hypoxia with centra-
lization of blood flow to vital organs. Inability to
increase adrenal perfusion during induced fetal hypoxia
is associated with cardio-vascular collapse and fetal
death [6].
The capacity to generate a stress response during
hypoxia/ischemia may be of vital importance beyond
that essential for hemodynamic adaptation. Increased
levels of CA in the CNS may serve an important role in
endogenous protection against inflammation and ische-
mia. From locus coeruleus and nuclei in the brain stem,
the cerebral cortex including the hippocampus, is widely
innervated by noradrenergic fibers. Several findings sup-
port the hypothesis that monoamines provide neuropro-
tection against ischemia by acting at cell populations
implicated in the development of ischemic neuronal
damage. In microglia, as in peripheral immune popula-
tions, NE induces immune-suppression by c-AMP
dependent mechanisms, characterised by reduced cyto-
kine release [7,8]. Norepinephrine also directly modu-
lates the excitability in neuronal cells and regulates the
release of neurotransmitters in the hippocampus [9-12].
Furthermore, monoamines promote neuronal survival by
inducing release of neurotrophins in astrocytes [13].
Inflammation and ischemia have a synergistic dama-
ging effect in the immature brain [14] and animal stu-
dies show that induced inflammation prior to ischemia,
depending on the applied time interval between the
respective insults, may heavily aggravate resulting neuro-
nal damage [15,16].
We have recently developed a model of induced
inflammation and “ischemia” in the neonatal brain using
juvenile murine organotypic hippocampal slice cultures.
We have shown that exposure to lipopolysaccharide
(LPS) immediately prior to oxygen-glucose deprivation
(OGD) heavily aggravated cell death in the neuronal
subregions, CA1, CA3 and the dentate gyrus (DG) [17].
The sensitizing effect of LPS to OGD was dependent on
signalling by tumor necrosis factor (TNF) -a through
TNF receptor 1 (TNFR1). Absence of TNFR1 was
associated with decreased levels of secreted TNF-a dur-
ing LPS exposure. Thus, signalling by TNF-a is a key
mechanism in inflammatory induced sensitization to
ischemia. Of note, neuronal cell death following OGD
with LPS pre-exposure could be completely blocked by
a NMDA-receptor antagonist showing that signalling by
TNF-a through TNFR1 resulted in enhanced excitotoxic
cell death [17].
Adrenoceptor (AR) stimulation has both immuno-
modulating effects and interacts with excitoxic mechan-
isms in cell populations within the brain [3,9]. We
therefore hypothesized that AR stimulation may provide
neuroprotection in LPS-induced sensitization to OGD in
the immature hippocampus. The organotypic hippocam-
pal slice culture offers the study of CNS parenchyma in
an intact three-dimensional tissue architecture and the
evaluation of the integrated response of various cellular
elements [18,19]. This is an advantage as both ischemic
damage and protection provided by immuno-modula-
tion is thought to result from activation of multiple cell
types in the brain and their interactions. In addition, the
effect of AR stimulation can be studied locally within
brain tissue excluding effects from cardiovascular
changes.
We investigated the effect of a1-, a2-, b1- and b2-AR
activation respectively on neuronal cell death following
OGD with LPS pre-exposure in the immature murine
hippocampus. To characterise neuronal damage we
measured levels of cell death over time. Immune
response was characterised by determining levels of
released cytokines and by histological evaluation of
microglial morphology. To evaluate if neuroprotection
by AR activation depended on modified signalling
through TNFRs we performed separate studies in slices
from mice devoid of TNFR1 and TNFR2 respectively.
Methods
Organotypic hippocampal tissue cultures
All animal experiments were approved by the Malmo/
Lund ethical committee on animal experiments
(approval number M 73-04). Offspring from date-mated
balb/c mice (Harlan, Scandinavia, Denmark) and
C57BL/6 TNFR1
-/- and TNFR2
-/- mice were used for
experiments. In house breeding generated TNFR1
-/- and
TNFR2
-/- mice as described previously [17]. In brief,
hippocampal organotypic tis s u ec u l t u r e sw e r ep r e p a r e d
essentially according to the method of Stoppini, as
described earlier [18,20], from 6-day-old mice. In short,
hippocampi were dissected in ice-cold Hank’s balanced
salt solution, with 20 mmol/L HEPES (4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid), 100U penicil-
lin-streptomycin per milliliter, and 3 mg/mL D-glucose
and cut into 250-μm-thick slices using a McIllwain
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culture inserts, one per insert (0.4 mm Millicell-CM, 12
mm in diameter, Millipore Corp, Bedford, MA, USA).
Slices were cultured in 35°C and 90% to 95% humidity
in a CO2 incubator for 9 days before experiment. The
culture medium consisted of 50% modified Eagle’sm e d -
ium with Earle’s balanced salt solution (MEM), 25%
horse serum, and a 18% Hank’s balanced salt solution
and was supplemented with 4 mmol/L L-glutamine, 50
units penicillin-streptomycin per milliliter, and 20
mmol/L D-glucose. The pH was adjusted to 7.2 using
NaHCO3. During the first week of culture, 2% of the
supplement B27 was included in the medium and there-
after omitted and replaced with the same volume of
water. On in vitro day 9, when the experiment was
initiated, horse serum was omitted and the volume was
replaced with MEM. This medium was used throughout
the experimental protocol. Before experimental start, the
culture medium was changed the day after the prepara-
tion and thereafter three times a week. All substances
were obtained from Invitrogen (Carlsbad, CA, USA)
with the exception of D-glucose, which was from
Sigma-Aldrich (St Louis, MO, USA).
Experimental protocol
All cultures used in one experiment were prepared from
mice pups from one to two females with litters born on
the same day. Experiments were started on DIV9, and
slices were assorted into four groups with one slice
from each individual mouse per experimental group and
six slices per group. Slices were incubated with propi-
dium iodide (PI, Sigma-Aldrich) for 1 h to assess the
background levels of cell death. Photomicrographs were
taken using fluorescent light microscopy and slices were
again sorted to include only undamaged slices displaying
n oP Iu p t a k e .L i g h tm i c r o s c o p yw a su s e dt oi n c l u d e
only slices with an organotypic anatomy. Propidium
iodide was present in the medium throughout the
experimental protocol and all experiments were carried
out in serum-free medium. Experimental groups that
were investigated are as follows: Control = cultures
exposed to medium changes at corresponding time
points as experimental groups, preincubation period of
24 h followed by transfer to fresh medium for 48 h; LPS
+OGD = incubation with LPS (1 μg/mL; Sigma-Aldrich)
for 24 h followed by oxygen-glucose deprivation (OGD)
and thereafter transfer to fresh medium for 48 h; Oxy-
gen-glucose deprivation (OGD) = preincubation without
LPS for 24 h, followed by OGD and thereafter transfer
to fresh medium for 48 h.
The effect of adrenergic agonists on neuronal cell
death was evaluated following LPS+OGD. The preferen-
tial b1-agonist dobutamine (5, 10 or 50 μM, Sigma,
Saint Louis, MO, USA), the preferential b2-agonist
terbutaline (5, 10 or 50 μM, Sigma), the a1-agonist
phenylephrine (5 or 50 μM, Sigma) and the a2-agonist
clonidine (5 or 50 μM, Sigma) were added in separate
experiments during the pre-incubation period of 24 h
with LPS.
In further experiments, b1- and b2-receptor specific
effects were evaluated by co-incubating the preferential
b1-agonist dobutamine with either CGP 20712A
(50 μM, Sigma), a selective b1-antagonist, or ICI 118551
(50 μM, Sigma), a selective b2-antagonist, during the
pre-incubation period as described above. An overview
of the experimental protocol is given in Figure 1.
The effect of b1-agonist dobutamine on neuronal cell
death following pure OGD (excluding LPS exposure
prior to OGD) was evaluated separately with the aim of
evaluating effects on primarily excitotoxic cell death.
Further, the effect of dobutamine on cell death following
LPS + OGD was evaluated in slices from TNFR1
-/- and
TNFR2
-/- mice in order to assess the role of signaling by
TNF-a through TNFR1 and TNFR2, respectively.
Before OGD, cultures were washed once in pre-
warmed phosphate-buffered saline (PBS) and transferred
to the anaerobic incubator (Elektrotek Ltd, Keighley,
UK) in an empty pre-warmed plate according to pre-
viously described protocols for OGD [20]. The anaerobic
incubator had an atmosphere comprising 10% H2,5 %
CO2,a n d8 5 %N 2, and the temperature was maintained
at 35 ± 0.3°C. Inside the incubator, the slices were trans-
ferred to wells containing pre-equilibrated OGD med-
ium. The OGD medium consisted of, in mmol/L
concentrations, 2 CaCl2, 125 NaCl, 25 NaHCO3,2 . 5
KCl, 1.25 NaH2PO4,2M g S O 4,a n d1 0s u c r o s ea n dh a d
a pH of 7.4. After 15 mins of OGD, the slices were
transferred to fresh oxygenated culture medium and
placed in the CO2 incubator. In all groups, slices were
cultured for 48 h after the time point of OGD, and
photomicrographs were taken in parallel at 4, 12, 24,
and 48 h after OGD.
Quantification of cell damage
Propidium iodide was used as a marker for cell death
and was included in the medium in all groups through-
out the experimental protocol [20]. Photomicrographs
of PI-stained slices were obtained before experimental
start and at time points of 4, 12, 24, and 48 h after
OGD in all groups. Densitometric analysis was per-
formed on photomicrographs to obtain quantitative
values of cell death. Propidium iodide intensity was
measured using a standardized area of interest applied
over the CA1 region. The CA1 region provided the
most consistent and reproducible damage following the
insults. Background uptake was measured in an unda-
maged area outside the CA2 region in each individual
slice, and values of cell death in regions of interest were
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intensity in the background region in each slice from
the mean fluorescent intensity values in the region of
interest. For image processing, the commercial software
Image-Pro Plus 4.0 (Media Cybernetics, MD, USA) was
used.
Immunohistochemistry
Slices were fixed for immunohistochemistry at 48 h after
OGD. Unsectioned slices were immunostained for the
microglial marker F4/80. Slices were fixed with 4% paraf-
ormaldehyde in PBS for 10 mins and then stored at 4°C
in PBS until used. Endogenous peroxidase activity was
quenched with 3% hydrogen peroxide in 10% methanol
f o r3 0m i n s .A f t e rr i n s i n g ,s lices were blocked with nor-
mal swine serum and diluted in PBS with 1% Triton X-
100 for 1 h before overnight incubation with a primary
antibody, monoclonal rat anti-F4/80 (Serotec, Kidlington,
Oxford, UK, diluted 1:1,000 in PBS containing 5% normal
rabbit serum and 1% Triton X-100). After rinsing, slices
were incubated with a biotinylated secondary antibody,
rabbit anti-rat IgG antibody. The secondary antibody was
diluted at 1:1,000 in PBS containing 1% Triton X-100
and swine serum for 90 mins. After rinsing, slices were
incubated with the avidin-biotin-peroxidase complex
(Vectastain Elite, Vector Laboratories Inc., Burlingame,
CA, USA) for 1 h before reaction with the chromogen
3,3 diaminobenzidine supplemented with 0.06% nickel
(DAB-Safe; 0.5 mg/mL; Saveen-Werner AB, Malmo,
Sweden). Serum and the secondary antibody and the avi-
din-biotin-peroxidase complex (Vectastain Elite) were
from Vector Laboratories. Micrographs of immunos-
tained slices were prepared using a microscope (Olympus
BX51) equipped for brightfield microscopy with a digital
camera (Olympus U-PMTVC). Figures show original,
unmodified photomicrographs.
Cytokine measurements
Levels of secreted cytokines in culture medium were
determined at 12 and 24 h after the start of LPS pre-
incubation with or without dobutamine/terbutaline and
at 12, 24, and 48 h after OGD. Samples of medium (50
μL) were immediately frozen on dry ice and were there-
after stored at -80°C until analyzed in one batch. Levels
of TNF-a, monocyte chemoattractant protein 1 (MCP-
1) and interleukin (IL)-6 were determined by cytometric
bead assay (Becton Dickinson (BD) Biosciences, San
Jose, CA, USA) and flow cytometry according to the
manufacturer’s recommendations and as described ear-
lier [2]. Two-color flow cytometric analyses were per-
formed using a FACSCalibur Flow Cytometer (BD
Biosciences). Data were acquired and analyzed using BD
Biosciences CBA software. The lower limit of detection
for the various cytokines evaluated ranged from 2 to 10
pg/mL. For results above the upper limit of detection,
serial dilution of the sample was performed to accu-
rately determine cytokine levels. A level of 0.1 pg/mL
was regarded as non-detectable.
Figure 1 Schematic illustration of experimental design. LPS = lipopolysaccharide; PI = propidium iodide; OGD = oxygen-glucose deprivation;
IHC = immunohistochemistry; b1-agonist = dobutamine; b2-agonist = terbutaline; a1- agonist = phenylephrine; a2-agonist = clonidine.
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Statistical analysis was performed using SPSS v14.0 for
Windows. Data are expressed as mean ± SEM. All com-
pared groups were run in parallel inside the anaerobic
incubator. Differences between groups were assessed
using ANOVA for repeated measures with post hoc
Bonferroni correction for multiple comparisons. Varia-
bility between experimental dates was adjusted for by
including date as a variable. P-values of <0.05 were con-
sidered significant.
Results
Neuronal cell death following lipopolysaccharide
exposure and oxygen-glucose deprivation
Representative photomicrographs and mean values of
cell death illustrating aggravated neuronal cell death fol-
lowing LPS + OGD as compared to pure OGD are
shown in Figure 2.
Cell damage induced by OGD only, was seen from
4 h, and reached its maximal level by 12 h of reoxygena-
tion, (hatched bars). Pre-incubation with LPS during 24
h before OGD severely aggravated cell damage as com-
p a r e dt os o l ee x p o s u r et oO G D( p<0 . 0 0 1r e s p e c t i v e l y )
(white bars). The time course of cell damage was similar
to pure OGD. Sole exposure to LPS did not damage
cells in the CA1 region up to 72 h following exposure.
Control slices exhibited no cell damage.
Protective effect of adrenergic agonists on neuronal
death following lipopolysaccharide exposure and oxygen-
glucose deprivation
Effect of adrenergic agonists on neuronal cell death fol-
lowing LPS+OGD was evaluated by co-incubating slices
with the respective adrenergic agonists during the 24 h
o fL P Se x p o s u r e ,F i g u r e2 .T h eb1-agonist dobutamine
and the b2-agonist terbutaline both conferred protection
Figure 2 Effect of b1-agonist dobutamine on neuronal cell death following lipopolysaccharide-induced sensitization to OGD in murine
hippocampal slice cultures. A. Temporal development of cell damage (mean fluorescence intensity (MFI)) after 15 min oxygen-glucose
deprivation (OGD), LPS (1 μg/ml) for 24 h + 15 min oxygen-glucose deprivation (OGD), b1-agonist dobutamine, (5 μM) + 24 h LPS + 15 min
OGD and b1-agonist dobutamine (50 μM) + 24 h LPS + OGD. The same culture is shown at repeated time points of recovery. B. Cell death (MFI)
after 15 min OGD (hatched bars), 24 h LPS+ 15 min OGD (white bars), dobutamine (5 μM) + 24 h LPS + 15 min OGD (shaded bars) and
dobutamine (50 μM) + 24 h LPS + 15 min OGD (dark shaded bars) at repeated points of recovery. Data are shown as means ± SEM with n = 18.
LPS+OGD versus OGD, P < 0.001 in the CA1; dobutamine (5 μM) + LPS + OGD versus LPS + OGD, p < 0.01 in the CA1; dobutamine (50 μM) +
LPS + OGD versus dobutamine (5 μM) + LPS + OGD, p < 0.001 in the CA1. Repeated-measures ANOVA with post hoc Bonferroni.
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and 3. At a concentration of 5 μM, dobutamine offered
a 65% protection (p < 0.01 respectively), which further
improved (85%) at 50 μM (p < 0.01), Figure 2. This pro-
tection was completely obliterated by co-incubation with
both the specific b-antagonist CGP 20712A at 5 μM( p
<0.001) and with the specific b2-antagonist ICI 118551
at 5 μM, Figure 4.
To investigate the effect of preferential b2-AR activa-
tion, slices were preincubated with 5 μM terbutaline. At
this concentration terbulatine offered a 24% protection
(p < 0.01 respectively), that was further increased to
61% at 50 μM (p < 0.01), Figure 3. The neuro-protective
effect of dobutamine and terbutaline at equimolar con-
centrations was compared in a separate experiment. At
both 5 and 50 μM the effect of dobutamine was more
pronounced (2.7 fold at a concentration of 5 μMa n d
1.5 fold at a concentration of 50 μM) than that of terbu-
taline at corresponding concentrations (p < 0.01
respectively).
The a1-agonist phenylephrine offered a partial 44%
protection (p < 0.05 respectively) with a similar effect at
both concentrations (5 and 50 μM), Figure 5. In another
set of experiments co-incubation of LPS with the a2-
agonist clonidine (5 and 50 μM) did not affect neuronal
cell death at either concentration, Figure 6.
  -agonists depress cytokine levels in slices during
exposure to LPS and following LPS and OGD
We have previously demonstrated that LPS exposure is
associated with an increase in the secreted levels of
TNF-a,I L - 6a n dM C P - 1a t1 2a n d2 4h .F u r t h e r ,l e v e l s
of MCP-1 were increased at 24 and 48 h after LPS
exposure followed by OGD as compared with pure
OGD [17]. The effects of co-incubation with dobuta-
mine (50 uM) and terbutaline (50 uM) respectively on
cytokine secretion during LPS exposure and following
OGD were evaluated, Figure 7A. Secreted levels of the
pro-inflammatory cytokines TNFa,M C P - 1 ,a n dI L - 6i n
m e d i u mw e r ed e c r e a s e da t1 2a n d2 4hd u r i n gL P S
Figure 3 Effect of b2-agonist terbutaline on neuronal cell death following lipopolysaccharide-induced sensitization to OGD in murine
hippocampal slice cultures. A. Temporal development of cell damage (mean fluorescence intensity (MFI)) after 15 min oxygen-glucose
deprivation (OGD), LPS (1 μg/ml) for 24 h + 15 min oxygen-glucose deprivation (OGD), b2-agonist terbutaline, (5 μM) + 24 h LPS + 15 min OGD
and b2-agonist terbutaline (50 μM) + 24 h LPS + OGD. The same culture is shown at repeated time points of recovery. B. Cell death (MFI) after
15 min OGD (hatched bars), 24 h LPS+ 15 min OGD (white bars), terbutaline (5 μM) + 24 h LPS + 15 min OGD (shaded bars) and terbutaline (50
μM) + 24 h LPS + 15 min OGD (dark shaded bars) at repeated points of recovery. Data are shown as means ± SEM with n = 18. LPS+OGD
versus OGD, P < 0.001 in the CA1; terbutaline (5 μM) + LPS + OGD versus LPS + OGD, p < 0.01 in the CA1; terbutaline (50 μM) + LPS + OGD
versus terbutaline (5 μM) + LPS + OGD, p < 0.01 in the CA1. Repeated-measures ANOVA with post hoc Bonferroni.
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respectively) as where levels of MCP-1 at 24 and 48 h
following LPS + OGD (p < 0.01 respectively). The sup-
pressive effects of the respective b-agonists in equi-
molar concentrations on cytokine secretion during LPS
exposure and following LPS + OGD were similar.
Dobutamin depresses LPS- and OGD-induced microglial
activation
Hippocampal organotypic cultures from the respective
groups were stained with the microglial marker F4/80 at
12 h following start of LPS exposure and at 24 and 48 h
after OGD. Changes in staining intensity for F4/80 and
morphology have been described as early sensitive indica-
tors of microglial activation [21]. Control cultures dis-
played characteristically quiescent microglia, with
ramified cell bodies at all time points. LPS-exposed cul-
tures exhibited microglia with a swollen ameboid mor-
phology at 24 h after OGD which was more pronounced
at 48 h with microglia presenting a rough, densely stained
plasma membrane. Pure OGD resulted in a characteristic
distribution of activated microglia that was localized to
the CA1-CA3 cell band. Incubation with dobutamine
during the 24 h of LPS incubation resulted in the induc-
tion of a microglial morphology, which is unlike that
observed in both activated and resting microglia charac-
terised by ramified microglia with swollen cell bodies.
Representative illustrations of immuno-staining with F4/
80 in hippocampal slices are given in Figure 7B.
Effect of b1-agonist on pure OGD and in hippocampal
slices devoid of TNFR1 and TNFR2
Pre-incubation of slices with dobutamine (50 μM) 24 h
prior to pure OGD without pre-exposure to LPS,
resulted in a near total protection, 68%, without any
visible cell death (p < 0.001), Figure 8. As previously
shown, LPS-exposure prior to OGD in TNFR1
-/- slices
did not result in aggravated neuronal damage as com-
pared to exposure to pure OGD whereas the sensitiz-
ing effect of LPS to OGD was present in TNFR2-/-
slices [17]. Pre-incubation with dobutamine (50 μM)
during LPS exposure prior to OGD in hippocampal
slices from both TNFR1
-/- and TNFR2
-/- mice respec-
tively resulted in reduced cell death by 86% and 71%
respectively (all p < 0.01), Figure 9 and 10,
respectively.
Discussion
Together these results show that b-AR activation pro-
vides neuro-protection in the setting of LPS-induced
inflammation and OGD in the immature murine hippo-
campus. The neuro-protective effect was associated with
decreased levels of pro-inflammatory cytokines during
LPS exposure and a change in the morphological
appearance of microglia. In addition, b-AR activation
exhibited neuro-protective properties in pure OGD
without preceding inflammatory exposure and in hippo-
campal slices devoid of TNFR1.
Infection with pro-inflammatory exposure and
hypoxia-ischemia are both recognized as factors causing
white and grey matter brain damage during the transi-
tion from fetal to neonatal life. The aggravating effect of
induced inflammation on hypoxic-ischemic neuronal
damage has been well documented in vivo [15]. We
have previously characterized the sensitizing effect of
LPS exposure on neuronal damage following OGD in
juvenile murine hippocampal slice cultures and showed
that time separation between the respective insults was
decisive for resulting neuronal damage, ie for a sensitiz-
ing, or with an increased time separation, a protective
effect [17]. Thus, this in vitro organotypic hippocampal
slice culture system resembles in vivo experimental
models in an essential aspect and is suitable for
mechanistic studies.
Figure 4 Effect of b1-specific antagonist CGP 20712A or the
specific-b2 antagonist ICI 118551 on the protective effect of
dobutamine on neuronal cell death following
lipopolysaccharide-induced sensitization to OGD in murine
hippocampal slice cultures. Cell death (MFI) after 24 h LPS + 15
min OGD (white bars), dobutamine (5 μM) +24 h LPS +15 min OGD
(black bars), dobutamine (5 μM) + CGP 20712A (5 μM) + 24 h LPS +
15 min OGD (light shaded bars), dobutamine (5 μM) + ICI 118551 (5
μM) + 24 h LPS + 15 min OGD (dark shaded bars), at repeated
points of recovery. Data are shown as means ± SEM with n = 18.
Dobutamine (5 μM) + LPS + OGD versus LPS + OGD, p < 0.01 in
the CA1; dobutamine (5 μM) + CGP 20712A (5 μM) + LPS + OGD
versus dobutamine (5 μM) + LPS + OGD, p < 0.01 in the CA1;
dobutamine (5 μM) + ICI 118551 (5 μM) + LPS + OGD versus
dobutamine (5 μM) + LPS + OGD, p < 0.01 in the CA1 Repeated-
measures ANOVA with post hoc Bonferroni.
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Co-incubation of hippocampal slices during LPS expo-
sure with the b1-agonist dobutamine and the b2-agonist
terbutaline respectively resulted in a dose-dependent
reduction of neuronal cell death following OGD. How-
ever, at equi-molar concentrations the effect of dobuta-
mine was more pronounced than that of terbutaline
with dobutamine offering almost complete protection at
the higher concentration. However, co-incubation of
dobutamine with the b1 antagonist CGP 20712A or
with the b2 antagonist ICI 118551 clearly reversed the
protective effect. Therefore, it seems that the observed
protective effect is mediated via the b1- and the b2
receptors. As both receptors activate adenylate cylcase,
the likely mechanism is an increase in intracellular
cAMP levels that follow activation of either receptor.
Our results are in agreement with previous study
showing that both b1 and b2 agonists may produce neu-
roprotection against glutamate induced excitotoxicity in
mixed neuronal-glial cultures in vitro [22]. However, an
in vivo study by the same group, provided evidence that
the b2 AR is primarily responsible for the protective
effect provided by adrenergic stimulation in a model of
permanent middle cerebral artery occlusion in adult
mice [22]. b1 receptors are found at higher densities
than b2 receptors in normal mouse hippocampus [23],
however, b2 ARs are upregulated on astrocytes following
ischemia [24] which is accompanied by astrocyte activa-
tion. In vitro studies show that both b1 and b2 ARs may
induce astrocyte activation [22]. It seems both b1a n d
b2 ARs are involved in neuroprotection following ische-
mia and both astrocytes and neurons, as well as immune
cells are targeted by adrenergic stimulation [25].
Figure 5 Effect of a1-agonist phenylephrine on neuronal cell death following lipopolysaccharide-induced sensitization to OGD in
murine hippocampal slice cultures. A. Temporal development of cell damage (mean fluorescence intensity (MFI)) after 24 h LPS + 15 min
OGD, phenylephrine (5 μM) +24 h LPS +15 min OGD and phenylephrine (50 μM) +24 h LPS + 15 min OGD. The same culture is shown at
repeated time points of recovery. B. Cell death (MFI after 24 h LPS + 15 min OGD (white bars), phenylephrine (5 μM) +24 h LPS +15 min OGD
(shaded bars), phenylephrine (50 μM) +24 h LPS + 15 min OGD (dark shaded bars), at repeated points of recovery. Data are shown as means ±
SEM with n = 18. Phenylephrine (5 and 50 μM) + LPS + OGD versus LPS + OGD, p < 0.05 respectively in the CA1. Repeated-measures ANOVA
with post hoc Bonferroni.
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lowing induced inflammation and ischemia, however at
a magnitude lower than that found with either b-ago-
nist. The a2-agonist clonidine did not exhibit any dis-
cernible neuro-protective effects.
Immunomodulatory effects of b-adrenoceptor stimulation
Co-incubation with both   agonists, terbutaline and
dobutamine, during LPS-exposure caused a profound
down-regulation of secretion of TNF-a,I L - 6a n dM C P -
1 and morphological signs of modified microglial activa-
tion. The immuno-suppressive effect of b-AR stimula-
tion has been extensively studied in several brain cell
populations [3,4,26]. Binding to   AR and activation of
c-AMP dependent pathways has been shown to inhibit
the expression of numerous pro-inflammatory cytokines
[27], including TNFa in microglia [28,29]. The capacity
of microglia and monocytes to produce TNF-a and IL-
1b in response to LPS is efficiently reduced by b-AR
stimulation as well as by other c-AMP elevating agents
[3,4].
Neuroprotective mechanisms induced by b-adrenoceptor
stimulation
We have previously shown that signalling by TNF-a
through TNFR1 is essential for LPS-induced sensitiza-
tion or pre-conditioning to OGD and resulting severely
aggravated or reduced neuronal cell death. This suggests
that the immune modifying effect of b-agonist exposure
and, more specifically, the down-regulation of TNF-a
secretion, was critical for the observed neuro-protective
effect in the applied model of LPS-induced sensitization
to OGD. Although this was not tested, b-AR activation
may have been associated with increased neuronal cell
death if evaluated in the pre-conditioning model apply-
ing a prolonged time-interval between insults.
The neuro-protective effect of b-AR activation in both
pure OGD and in the combined insult LPS+OGD in
Figure 6 Effect of a2-agonist clonidine on neuronal cell death following lipopolysaccharide-induced sensitization to OGD in murine
hippocampal slice cultures. A. Temporal development of cell damage (mean fluorescence intensity (MFI)) after 24 h LPS + 15 min OGD,
clonidine (5 μM) +24 h LPS +15 min OGD and clonidine (50 μM) +24 h LPS + 15 min OGD. The same culture is shown at repeated time points
of recovery. B. Cell death (MFI) after 24 h LPS + 15 min OGD (white bars), clonidine (5 μM) +24 h LPS +15 min OGD (shaded bars bars),
clonidine (50 μM) +24 h LPS + 15 min OGD (dark shaded bars), at repeated points of recovery. Data are shown as means ± SEM with n = 18.
Clonidine(5 and 50 μM) + LPS + OGD versus LPS + OGD, non-significant differences at both concentrations) in the CA1.
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influences detrimental mechanisms other than down-
regulation of TNF-a. Recent studies have shown that b-
AR activation increases synthesis of the anti-oxidant glu-
tathione in cultured neurons as well as in mesenchymal
stem cells rendering protection against oxidative stress
[30,31]. Reinforcement of endogenous anti-oxidant pro-
duction may be a mechanism whereby b-AR activation
offered neuroprotection against both LPS-induced
inflammation and OGD in our hippocampal slice cul-
ture model.
The release of glutamate during OGD and the resulting
activation of excito-toxic mechanisms causing neuronal
cell death are well documented in this hippocampal slice
culture system [17]. We have previously shown that co-
incubation with the NMDA-receptor antagonist MK-801
efficiently protected all studied neuronal subregions from
cell death after pure OGD as well as that occurring after
OGD with LPS pre-exposure. Hypothetically, a direct
interference with NMDA-receptor activation by b-AR
activation could explain the profound neuroprotective
effects observed in the present study. Selective lesion of
locus coeruleus, with a subsequent decrease in hippo-
campal adrenergic input, greatly augments neuronal cell
death in the CA1 region following global cerebral ische-
mia in the adult rat [32]. In addition, b-AR activation has
Figure 7 b-adrenoceptor activation modulates lipopolysaccharide-induced inflammatory response before and after OGD in murine
hippocampal slice cultures. A. Mean concentrations of TNF-a, IL-6 and MCP-1 in culture medium at 12 and 24 h during 24 h of exposure to
LPS (1 μg/ml) +/- co-incubation with b1-agonist dobutamine (50 μM) or b2-agonist terbutaline (50 μM): only LPS (triangle), LPS+ dobutamine
(circle), LPS + terbutaline, (square). Far right, mean concentrations of MCP-1 at 24 and 48 h following 15 min OGD with pre-exposure to LPS for
24 h. N = 4 per experimental group at each time point. Error bars denote 1 SEM. Levels of TNF-a, IL-6 and MCP-1 were decreased by
dobutamine and terbutaline (p < 0.01 respectively) during LPS exposure as where levels of MCP-1 following LPS+OGD (p < 0.01). Repeated-
measures ANOVA with post hoc Bonferroni.B. F4/80 stained hippocampal slices illustrating microglial morphology. Immunohistochemistry was
performed at 48 h after 15 min OGD with pre-exposure to LPS (1 μg/ml) for 24 h. (1) 24 h LPS + 15 min OGD, (2) 24 h LPS + b1-agonist
dobutamine (50 μM) + 15 min OGD. Bars in 1 and 2 = 400 μm.
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transmission in the hippocampal CA1 region through an
increase in synaptic levels of adenosine thereby inhibiting
glutamate release by activating adenosine A1 receptors
[33]. In summary, the observed neuro-protective effect of
b-AR activation may include several mechanisms of exci-
tatory inhibition during OGD.
The individual capacity to increase levels of b-adrener-
gic agonists within the brain during exposure to inflam-
mation and ischemia may be decisive for resulting
degree of brain damage and functional impairment.
Thus activation of b-ARs by increased levels of NE may
be essential for endogenous neuro-protection.
Extracellular levels of NE in the hippocampus increase
30-fold during global ischemia in the adult rat brain
[34]. A corresponding increase of NE during ischemia in
the immature brain has to our knowledge not been stu-
died. However, the huge surge of circulating NE and E
released by the adrenomedullary system during fetal
hypoxia suggests a corresponding increase within the
immature brain during ischemia.
The organotypic hippocampal slice culture model
incorporates different cellular populations involved in
the coordinated response to pro-inflammation and
ischemia within the brain. Thus the present results were
not biased by perturbations in the cardio-vascular
Figure 8 Effect of b1-agonist dobutamine on neuronal cell death following OGD in murine hippocampal slice cultures.A .T e m p o r a l
development of cell damage (mean fluorescence intensity (MFI)) after 15 min oxygen-glucose deprivation (OGD) and b1-agonist dobutamine (50
μM) + OGD. The same culture is shown at repeated time points of recovery. B. Cell death (MFI) after 15 min OGD (hatched bars) and
dobutamine (50 μM) + 15 min OGD (shaded bars) at repeated points of recovery. Data are shown as means ± SEM with n = 18. Dobutamine
(50 μM) + OGD versus OGD, p < 0.01 in the CA1. Repeated-measures ANOVA with post hoc Bonferroni.
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mation in vivo comprise, apart from hemodynamic
adaptations, a primary induction of mechanisms at the
blood - endothelium interface with messengers evoking
a secondary intra-cerebral response. Continued study
will evaluate the possible neuro-protective effects of b-
adrenergic activation taking in to consideration the
interaction with the blood-brain barrier in vivo.
Conclusions
Modulation of CA levels during inflammation and ische-
mia may be a powerful means to achieve neuro-protection.
Continued study of mechanisms whereby CA mediate
their neuro-protective effects may provide information
useful for development of neuro-protective strategies.
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